Patent case: Use of dexmedetomidine for sedation in intensive care units, Austria
April 8, 2019
The Higher Regional Court of Vienna confirmed that the "second medical use" of an already known substance, as required for patent protection, can be that the substance is used for a specific group of patients with specific effects.
Case date: 11 May 2017
Case number: 34R113/16m
Court: Higher Regional Court of Vienna
A full summary of this case has been published on Kluwer IP Law.
Comments (0)
Your email address will not be published.
Become a contributor!
Interested in contributing? Submit your proposal for a blog post now and become a part of our legal community!
Contact Editorial Guidelines
